Tuesday, November 10, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Deep learning peptide sequencing stumbles on incomplete spectra, not model design

A benchmark of eight deep learning de novo peptide sequencing models finds that most errors stem from incomplete fragmentation spectra rather than model design, and that…

PR
By Priya Raman · Science Reporter
Nov 7 21:30 ETSource: Bioengineer.org

From the source

Deep learning peptide sequencing stumbles on incomplete spectra, not model design

A benchmark of eight deep learning de novo peptide sequencing models finds that most errors stem from incomplete fragmentation spectra rather than model design, and that post-processing offers little improvement.

Read at bioengineer.org
PeptiPrescribed peptides from $99/moSee all →